Crinetics股价盘前攀升2.7% 新药上市推动第四季度营收超500万美元

美股速递
Jan 05

Crinetics Pharmaceuticals Inc. (CRNX) 股价在盘前交易中上涨2.7%,此前该公司公布其新近上市的药物在第四季度创造了超过500万美元的营收。这一积极表现凸显了市场对该新药商业潜力的初步认可。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10